A comprehensive view of Over-the-Counter (OTC) Products. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Bayer launches Iberogast in the US, a plant-based digestive relief product developed after more than six decades of research; the proprietary blend is clinically proven to alleviate common digestive symptoms and is available on Amazon and major retailers
Published:
April 24, 2024
by Bayer AG
|
Cardinal Health to build a new 350,000-square-foot DC in central Ohio to expand its distribution capacity for OTC products, creating around 100 jobs by summer 2025; this will be Cardinal Health's fourth distribution facility in the region
Published:
April 02, 2024
by Columbus Dispatch (OH)
|
Dexcom receives FDA approval for OTC Stelo biosensor wearable glucose monitor that targets people not on insulin and without problematic hypoglycemia; the monitor measures and analyzes glucose levels and reports data via a smartphone app
Published:
March 06, 2024
by San Diego Union-Tribune (CA)
|
Brassica Pharma recalls eye ointment products sold at CVS and Walmart due to potential risk of infection after FDA cites lack of sterility assurance at manufacturing facility; no adverse reports received as of February 16
Published:
March 01, 2024
by WITI-TV (Milwaukee, WI)
|
Intrommune Therapeutics reveals positive data supporting Oral Mucosal Immunotherapy as a potential treatment for food allergies; the findings indicate that specially formulated toothpaste can deliver allergenic proteins
Published:
February 22, 2024
by GlobeNewswire
|
Ask us about our Tissue & Hygiene market view